Insider Trading & Ownership of Scott Dunseth Myers

Location: San Diego, CA
Summary: The estimated net worth of Scott Dunseth Myers is at least $5,852,666 dollars as of 10 Feb 2026. Scott Dunseth Myers is the Chief Executive Officer, Director of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $5.45M. Scott Dunseth Myers is the Director of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $403.2K.
Signature: Scott Dunseth Myers, by /s/ Trevor Dutcher, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Scott Dunseth Myers files a new Insider Trading report.

Ownership of Scott Dunseth Myers

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
VRDN	Viridian Therapeutics, Inc.\DE	Chief Executive Officer, Director	$5,449,500			12 Apr 2023
ZNTL	Zentalis Pharmaceuticals, Inc.	Director	$403,166	+$29,373	+7.9%	17 Jun 2025
DVAX	DYNAVAX TECHNOLOGIES CORP	Director	$0	+$41,116		10 Feb 2026
RNAC	Cartesian Therapeutics, Inc.	Director				13 Nov 2023
HARP	Harpoon Therapeutics, Inc.	Director				11 Mar 2024
TRIL	Trillium Therapeutics Inc.	Director				17 Nov 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.